|
RTGN RetinalGenix Technologies Inc 1836295 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-307,397.00 |
| Balance Sheet |
|
Current Assets
|
$27,232.00 |
|
Assets
|
$32,215.00 |
|
Current Liabilities
|
$2,670,178.00 |
|
Liabilities
|
$2,672,914.00 |
|
Equity
|
$-2,640,699.00 |
|
Shares Out
|
18843628.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-245,884.00 |
| Market Analysis |
Market Cap
|
$75,374,512.00 |
|
Price
|
$3.99 |
|
PB
|
0.75 |
|
EPS
|
-0.02 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:52 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:43 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RTGN documents filed with the SEC.
RTGN Filings
Clear
